Indication
Sleepiness due to obstructive sleep apnea
Sleepiness due to obstructive sleep apnea is a neurobehavioral manifestation characterized by an inability to maintain wakefulness and alertness during major awake hours, occurring secondary to chronic sleep-disordered breathing. Read more about Sleepiness due to obstructive sleep apnea
39 drugs 32 manufacturers
Drugs that treat it
Common Sleepiness due to obstructive sleep apnea therapies.
MODAFINIL
ARMODAFINIL
SUNOSI (solriamfetol HCl)
SUNOSI (solriamfetol HCl)
MODAFINIL
MODAFINIL
ARMODAFINIL
MODAFINIL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSleepiness due to obstructive sleep apnea is a neurobehavioral manifestation characterized by an inability to maintain wakefulness and alertness during major awake hours, occurring secondary to chronic sleep-disordered breathing.
Predominantly affecting adults, it results from recurrent episodes of partial or complete upper airway collapse during sleep, which trigger frequent microarousals, sleep fragmentation, and intermittent nocturnal hypoxemia.
This repetitive sleep disruption and associated neurochemical dysregulation in wake-promoting pathways lead to persistent diurnal somnolence, neurocognitive impairment, and reduced functional capacity, which may persist even in patients receiving primary airway therapies.
- nih.gov
Sleepiness due to obstructive sleep apnea is a neurobehavioral manifestation characterized by an inability to maintain wakefulness and alertness during major awake hours
- nih.gov
Sleepiness due to obstructive sleep apnea is a neurobehavioral manifestation characterized by an inability to maintain wakefulness and alertness during major awake hours, occurring secondary to chronic sleep-disordered breathing
- nih.gov
Predominantly affecting adults, it results from recurrent episodes of partial or complete upper airway collapse during sleep, which trigger frequent microarousals, sleep fragmentation, and intermittent nocturnal hypoxemia This repetitive sleep disruption and associated neurochemical dysregulation in wake-promoting pathways lead to persistent diurnal somnolence, neurocognitive impairment, and reduced functional capacity, which may persist even in patients receiving primary airway therapies
- nih.gov
Predominantly affecting adults, it results from recurrent episodes of partial or complete upper airway collapse during sleep, which trigger frequent microarousals, sleep fragmentation, and intermittent nocturnal hypoxemia
Personalize your experience
Follow Sleepiness due to obstructive sleep apnea and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.